Doris Staab

5.6k total citations
126 papers, 3.2k citations indexed

About

Doris Staab is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Allergy and Dermatology. According to data from OpenAlex, Doris Staab has authored 126 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 26 papers in Immunology and Allergy and 25 papers in Dermatology. Recurrent topics in Doris Staab's work include Cystic Fibrosis Research Advances (52 papers), Dermatology and Skin Diseases (25 papers) and Allergic Rhinitis and Sensitization (22 papers). Doris Staab is often cited by papers focused on Cystic Fibrosis Research Advances (52 papers), Dermatology and Skin Diseases (25 papers) and Allergic Rhinitis and Sensitization (22 papers). Doris Staab collaborates with scholars based in Germany, United States and United Kingdom. Doris Staab's co-authors include Ulrich Wahn, Manfred Becker, Klaus von Bergmann, Arturo Zychlinsky, Venizelos Papayannopoulos, Kerstin Wenninger, Rainer Kehrt, Rüdiger Szczepanski, Thomas L. Diepgen and S. Scheewe and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Doris Staab

120 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Staab Germany 32 1.2k 983 848 604 419 126 3.2k
Somnath Mukhopadhyay United Kingdom 28 960 0.8× 505 0.5× 567 0.7× 1.1k 1.9× 190 0.5× 88 2.5k
Ramesh Kurukulaaratchy United Kingdom 32 1.3k 1.1× 359 0.4× 1.0k 1.2× 2.1k 3.4× 244 0.6× 116 3.1k
Rajesh Kumar United States 32 1.2k 1.0× 350 0.4× 1.5k 1.7× 1.9k 3.2× 849 2.0× 146 4.6k
Alexander C. Ferguson Canada 35 1.1k 0.9× 465 0.5× 1.2k 1.4× 2.0k 3.4× 276 0.7× 86 3.7k
Stephen A. Tilles United States 27 740 0.6× 1.2k 1.2× 2.3k 2.7× 1.8k 3.0× 373 0.9× 89 4.2k
F. Estelle R. Simons Canada 31 786 0.7× 710 0.7× 2.4k 2.8× 1.7k 2.8× 393 0.9× 68 3.7k
Anne K. Ellis Canada 36 402 0.3× 747 0.8× 1.9k 2.2× 1.5k 2.5× 375 0.9× 198 3.7k
Ioana Agache Romania 34 903 0.8× 708 0.7× 1.9k 2.2× 2.5k 4.2× 406 1.0× 128 4.0k
Chitra Dinakar United States 24 389 0.3× 197 0.2× 732 0.9× 692 1.1× 230 0.5× 91 2.1k
Enrico Heffler Italy 37 1.8k 1.5× 430 0.4× 1.8k 2.1× 2.9k 4.8× 713 1.7× 248 5.1k

Countries citing papers authored by Doris Staab

Since Specialization
Citations

This map shows the geographic impact of Doris Staab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Staab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Staab more than expected).

Fields of papers citing papers by Doris Staab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Staab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Staab. The network helps show where Doris Staab may publish in the future.

Co-authorship network of co-authors of Doris Staab

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Staab. A scholar is included among the top collaborators of Doris Staab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Staab. Doris Staab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roehmel, Jobst, Alexander Rohrbach, Doris Staab, et al.. (2023). Lymphocyte transformation tests predict delayed-type allergy to piperacillin/tazobactam in patients with cystic fibrosis. Journal of Cystic Fibrosis. 23(3). 573–578.
2.
Reinauer, Christina, Sascha R. Tittel, Annabel Sandra Mueller‐Stierlin, et al.. (2023). Outpatient screening for anxiety and depression symptoms in adolescents with type 1 diabetes - a cross-sectional survey. Child and Adolescent Psychiatry and Mental Health. 17(1). 142–142. 9 indexed citations
3.
Rotter, Gabriele, Michael Teut, Miriam Ortiz, et al.. (2022). Hypnotherapy, Intermittent Fasting, and Exercise Group Programs in Atopic Dermatitis: A Randomized Controlled Explorative Clinical Trial During the COVID-19 Pandemic. Journal of Integrative and Complementary Medicine. 29(2). 99–110. 9 indexed citations
4.
Ernst, Gundula, et al.. (2022). Two-Year Follow-Up of a Transition-Specific Education Program for Young People With Chronic Conditions. Journal of Adolescent Health. 71(3). 344–350. 8 indexed citations
5.
Niewerth, Martina, Claudia Sengler, Daniel Windschall, et al.. (2021). POS1321 MENTAL HEALTH SCREENING IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS. Annals of the Rheumatic Diseases. 80. 943–943. 3 indexed citations
6.
Abbott, Janice, et al.. (2018). Mental Health screening in cystic fibrosis centres across Europe. Journal of Cystic Fibrosis. 18(2). 299–303. 25 indexed citations
7.
Johnson, Colin, Rob Arbuckle, Nicola Bonner, et al.. (2017). Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument. Patient. 10(5). 615–628. 35 indexed citations
8.
Staß, Heino, Heinz Delesen, Johannes Nagelschmitz, & Doris Staab. (2014). Safety and Pharmacokinetics of Ciprofloxacin Dry Powder for Inhalation in Cystic Fibrosis: A Phase I, Randomized, Single-Dose, Dose-Escalation Study. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(2). 106–115. 40 indexed citations
9.
Bilton, Diana, T. Pressler, Marco Cipolli, et al.. (2013). PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA. Pediatric Pulmonology. 48. 290–290. 15 indexed citations
10.
Roehmel, Jobst, C. Schwarz, Anne Mehl, Philippe Stock, & Doris Staab. (2013). Hypersensitivity to antibiotics in patients with cystic fibrosis. Journal of Cystic Fibrosis. 13(2). 205–211. 30 indexed citations
11.
12.
Hollmeyer, Helge, et al.. (2012). Cost of Illness of Cystic Fibrosis in Germany. PharmacoEconomics. 30(9). 763–777. 30 indexed citations
13.
Geller, David E., Patrick A. Flume, Doris Staab, et al.. (2011). Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa. American Journal of Respiratory and Critical Care Medicine. 183(11). 1510–1516. 118 indexed citations
14.
Flume, Patrick A., David E. Geller, Doris Staab, et al.. (2010). Effects of inhaled MP-376 (aeroquin, levofloxacin inhalation solution) on lung function in stable cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (PA) lung infection. Journal of Cystic Fibrosis. 9. S23–S23. 18 indexed citations
15.
Rietschel, E., et al.. (2010). Pharmacokinetics of continuous treatment with o.d. or b.i.d. inhalation of tobramycin (TOBI™). Journal of Cystic Fibrosis. 9. S23–S23. 8 indexed citations
16.
Steinkamp, Gratiana, Sabina Schmitt‐Grohé, Gerd Döring, et al.. (2008). Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection. Respiratory Medicine. 102(11). 1643–1653. 41 indexed citations
17.
18.
Staab, Doris. (2004). Cystic fibrosis -- therapeutic challenge in cystic fibrosis children. European Journal of Endocrinology. 151(Suppl_1). S77–S80. 25 indexed citations
19.
Wenninger, Kerstin, et al.. (2003). The revised German Cystic Fibrosis Questionnaire: Validation of a disease-specific health-related quality of life instrument. Quality of Life Research. 12(1). 77–85. 51 indexed citations
20.
Rolinck‐Werninghaus, Claudia, Karsten Kötz, K. Magdorf, et al.. (2001). Late clinical manifestation of cerebral tuberculomas in two children with tuberculous meningoencephalitis. European Journal of Pediatrics. 160(11). 645–648. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Somnath Mukhopadhyay Breakdown of academic impact, for papers by Ramesh Kurukulaaratchy Breakdown of academic impact, for papers by Rajesh Kumar Breakdown of academic impact, for papers by Alexander C. Ferguson Breakdown of academic impact, for papers by Stephen A. Tilles Breakdown of academic impact, for papers by F. Estelle R. Simons Breakdown of academic impact, for papers by Anne K. Ellis Breakdown of academic impact, for papers by Ioana Agache Breakdown of academic impact, for papers by Chitra Dinakar Breakdown of academic impact, for papers by Enrico Heffler
Rankless by CCL
2026